Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurogenic inflammation in airways.

P J Barnes1

  • 1Department of Thoracic Medicine, National Heart and Lung Institute, Royal Brompton Hospital, London, UK.

International Archives of Allergy and Applied Immunology
|January 1, 1991
PubMed
Summary

Neurogenic inflammation involves neuropeptide release from sensory nerves, contributing to asthma. Strategies exist to reduce this inflammation, offering potential therapeutic avenues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid resistance in asthma.

American journal of respiratory and critical care medicine·1995
Same author

Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.

The Journal of experimental medicine·1995
Same author

Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.

Molecular pharmacology·1995
Same author

Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages.

The American journal of physiology·1995
Same author

Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction.

Thorax·1995

Area of Science:

  • Immunology
  • Neuroscience
  • Respiratory Medicine

Background:

  • Neurogenic inflammation, mediated by neuropeptides from sensory nerves, is implicated in airway inflammation, particularly in asthma.
  • Key neuropeptides like substance P and neurokinin A contribute to bronchoconstriction, vasodilation, plasma exudation, and mucus secretion in the airways.
  • Sensory nerve sensitization by inflammatory mediators can lead to exaggerated inflammatory responses.

Purpose of the Study:

  • To review the role of neurogenic inflammation in airway diseases.
  • To discuss the mechanisms of neuropeptide release and their effects on airway function.
  • To explore potential therapeutic strategies targeting neurogenic inflammation.

Main Methods:

  • Review of existing literature on neurogenic inflammation in airways.
  • Analysis of neuropeptide function and their receptors.
  • Discussion of enzyme activity, such as neutral endopeptidase, in neuropeptide degradation.

Main Results:

  • Neuropeptides released from sensory nerves significantly impact airway physiology.
  • Sensory nerves can be sensitized, amplifying inflammatory responses.
  • Epithelial cell enzyme activity, like neutral endopeptidase, influences neuropeptide effects.

Conclusions:

  • Neurogenic inflammation is a key component of airway inflammatory diseases, including asthma.
  • Understanding these mechanisms provides targets for novel therapeutic interventions.
  • Modulating neuropeptide activity and sensory nerve function offers potential treatment strategies.

Related Experiment Videos